Close

More on CRVO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+21.4% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (2/12/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CervoMed (NQ:CRVO)
Delayed: 9.72 +0.02 (0.21%)
Prev. Close $9.70  
Open$10.44 
52 Wk High$ 
52 Wk Low$ 
Day High$10.79 
Day Low$9.36 
P/E N/A  
EPS$ 
Volume102,268 

Friends, Peers and Foes (?): GCTK, HLOC, DRMA, IPWR, M (more...)

Dec 5, 2024 04:17 PM Roth/MKM Starts CervoMed (CRVO) at Buy
Dec 5, 2024 06:05 AM H.C. Wainwright Starts CervoMed (CRVO) at Buy
Dec 3, 2024 07:01 AM Form 8-K CervoMed Inc. For: Dec 03
Nov 27, 2024 04:02 PM Form 8-K CervoMed Inc. For: Nov 27
Nov 27, 2024 07:02 AM CervoMed (CRVO) Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia
Nov 27, 2024 07:00 AM CervoMed Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia
Nov 18, 2024 07:16 AM D. Boral Capital Starts CervoMed (CRVO) at Buy
Nov 14, 2024 03:09 PM Form SC 13G CervoMed Inc. Filed by: AWM Investment Company, Inc.
Nov 13, 2024 04:02 PM Form 8-K CervoMed Inc. For: Nov 08
Nov 13, 2024 08:00 AM CervoMed (CRVO) Announces Key Senior Leadership Appointments
View All Articles

Entities mentioned with CRVO

View All Entities